跳至主要内容
临床试验/NCT04996342
NCT04996342招募中不适用

A Cohort Study of Chronic Cardiovascular Diseases in the Department of Cardiology, Peking University First Hospital

Peking University First Hospital1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2021年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10,000
试验地点
1
主要终点
Major Adverse Cardiovascular Events

研究概览

简要总结

This prospective cohort study aims to establish cohorts of patients with chronic cardiovascular disease, including refractory and secondary hypertension, coronary heart disease, atrial fibrillation, ventricular arrhythmias, structural heart disease, pulmonary hypertension, heart failure and rare diseases of the cardiovascular system, and patients with implantations of cardiac pacemaker, in order to dynamically describe the population characteristics, diagnosis and treatment status and long-term prognosis and analyze the factors affecting the choice of treatment plan, long-term management quality and clinical prognosis of these patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed as refractory hypertension and/or secondary hypertension
  • Patients willing to accept long-term follow-up and regular return visits

排除标准

  • Severe diseases of other systems may affecting the life span of patients
  • Coronary heart disease
  • Inclusion Criteria:
  • Patients undergoing coronary angiography and interventional therapy in the cath lab
  • Patients undergoing coronary angiography and functional assessment in the cath lab
  • Patients diagnosed as acute myocardial infarction
  • Exclusion Criteria:
  • Severe diseases of other systems may affecting the life span of patients
  • Regular return visits not available
  • Atrial fibrillation
  • Inclusion Criteria:
  • PAtrial fibrillation diagnosed by electrocardiogram or holter (duration >30 seconds)
  • Patients willing to accept long-term follow-up and regular return visits
  • Exclusion Criteria:
  • Severe diseases of other systems may affecting the life span of patients
  • New-onset atrial fibrillation during the perioperative period of major surgery
  • Ventricular arrhythmias
  • Inclusion Criteria:
  • Patients diagnosed as ventricular tachycardia, ventricular premature beat
  • Patients willing to accept long-term follow-up and regular return visits
  • Exclusion Criteria:
  • Severe diseases of other systems may affecting the life span of patients
  • A transient cause of ventricular arrhythmia was determined by the doctor, and long-term follow-up was not required
  • Cardiac pacemaker implantation
  • Inclusion Criteria:
  • Patients with permanent pacemaker implantations due to various causes (including bradycardia pacing, implantable cardioverter defibrillator, cardiac resynchronization therapy, leadless cardiac pacemaker, etc.)
  • Patients willing to accept long-term follow-up and regular return visits
  • Exclusion Criteria:
  • Severe diseases of other systems may affecting the life span of patients
  • Structural heart disease
  • Inclusion Criteria:
  • Patients diagnosed as structural heart disease, including congenital heart disease and severe valvular disease (moderate and above valvular stenosis or incomplete closure)
  • Patients willing to accept long-term follow-up and regular return visits
  • Exclusion Criteria:
  • Severe diseases of other systems may affecting the life span of patients
  • Pulmonary hypertension
  • Inclusion Criteria:
  • Patients diagnosed as pulmonary hypertension
  • Patients willing to accept long-term follow-up and regular return visits
  • Exclusion Criteria:
  • Severe diseases of other systems may affecting the life span of patients
  • Heart failure
  • Inclusion Criteria:
  • Patients diagnosed as heart failure
  • Patients willing to accept long-term follow-up and regular return visits
  • Exclusion Criteria:
  • Severe diseases of other systems may affecting the life span of patients
  • Rare diseases of the cardiovascular system
  • Inclusion Criteria:
  • Patients diagnosed as rare diseases in the catalog published by National Health Commission of the People's Republic of China
  • 另有 3 项未显示

结局指标

主要结局

Major Adverse Cardiovascular Events

时间窗: 5 year

Time to the first occurence of Any cause death, myocardial infarction, or Stroke

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jianping LI

Director of Department of Cardiology

Peking University First Hospital

研究点 (1)

Loading locations...

相似试验